Skip to main content

Sinna kansɛri suguya jɔnjɔnw ye jumɛnw ye? (Sin kansɛri suguyaw) An k’a faamuya cogo nɔgɔman na

Sinna kansɛri suguya jɔnjɔnw ye jumɛnw ye? (Sin kansɛri suguyaw) An k’a faamuya cogo nɔgɔman na

Siran ni sɛgɛn min bɛ i la ni i y’a ye ko sinji kansɛri bɛ i la, a ka gɛlɛn ka o fɔ daɲɛw la. Ɲininkali caman bɛ i hakili la kosɛbɛ. A bɛ kɛ cogoya la ka ɲininkaliw kɛ i n'a fɔ "Mun na nin kɛra ne la?", "Ne bɛ mun kɛ sisan?", "Yala nin bɛ se ka furakɛ wa?". Nin taama in na, n b’a ɲini ka fɛnw ɲɛfɔ cogo nɔgɔman na ani kan na i bɛ se ka min faamuya. K’a dɔn tigitigi kansɛri suguya min bɛ i la, o bɛ i n’a fɔ ka jugu faamuya sani i ka kɛlɛ daminɛ. O de ye fɛɛrɛ fɔlɔ ye min nafa ka bon kosɛbɛ furakɛli sugandili la min bɛ bɛn aw ma.

Sinna kansɛri min bɛ sɔrɔ ɔrimɔni minɛbaga fɛ

Nin ye sinji kansɛri suguya ye min ka ca. Ni an y’a fɔ k’a jɛya, sinji kansɛri 100 o 100, 80 ɲɔgɔn bɛ don o kulu kɔnɔ.

O la, nin "hormone-dependent" in kɔrɔ ye mun ye?

Miiri o la dɔrɔn. An farikolo, kɛrɛnkɛrɛnnenya la musow farikolo, bɛ ni ɔrimɔni fila ye minnu bɛ sɔrɔ u yɛrɛ la, n’olu bɛ wele ko ɔrimɔni ni porojɛsitɛri . Olu nafa ka bon kosɛbɛ taabolo nɔgɔmanw na an farikolo la. Nka, kansɛribana dɔw bɛ "dɔlɔminna" kosɛbɛ o ɔrimɔni ninnu na. O kɔrɔ ye ko nin kansɛribana ninnu sanfɛ, "recepteurs" walima da dɔw bɛ yen, o ɔrimɔni ninnu bɛ se ka na minnu na ka nɔrɔ u la. Ni ɔrimɔni ɔrimɔni nana o da gosi, kansɛribanakisɛ bɛ balo sɔrɔ a la, wa a bɛ daminɛ ka bonya ka tila. I n’a fɔ n’i ye jiri dɔ jigin cogo min na, a bɛ bonya ka taa a fɛ cogo min na.

Ni aw ka furakɛli sɛbɛn ko `ER-positive` (Estrogen Receptor-Positive), o kɔrɔ ye ko aw ka kansɛribanakisɛw bɛ u yɛrɛ minɛ ɔrimɔni ɔrimɔni na. Ni a ko `PR-positif` (Progesterone Receptor-Positive), o kɔrɔ ye ko a bɛ porojɛsitɛri ɔrimɔni sɛgɛsɛgɛ. Ni a bɛ se ka ninnu dɔ la kelen sɔrɔ, kansɛri bɛ wele ko kansɛri min bɛ sɔrɔ ɔrimɔni minɛbaga fɛ .

Tiɲɛ na, nin ye kibaru duman ye cogo dɔ la. Sabula n’an y’a dɔn kansɛri bɛ baara kɛ ni min ye ka bonya, an bɛ se k’o sira bali ka kansɛri kunbɛn. O de ye "hormone therapy" ye.

A ka ca a la, ɔrimɔni furakɛli bɛ kɛ opereli, chimiothérapie walima radiyodisiyɔn kɔfɛ walasa kansɛri kana segin ka na. O fura ninnu bɛ baara kɛ ni kansɛribanakisɛw ka "da" datuguli ye, walima ka farikolo bali ka ɔrimɔni dilan.

Furakɛli suguyaƝɛfɔli nɔgɔmanw ni misaliw
SERMw (ER Modulateurs sélectifs) . Olu bɛ ɔrimɔni minɛbaga bali kansɛribanakisɛ la, o bɛ ɔrimɔni bali ka don. Misaliw: Tamokisifɛni, Toremifeni .
SERDw (Estrogène récepteur degradeurs sélectifs) . Olu tɛ a minɛbaga bali dɔrɔn, nka u b’a tiɲɛ fana. Misaliw: Fulvestrant (Faslodex), Elacestrant (Orserdu) .
Aromatase (Aromatase) balilanw Olu bɛ farikolo bali ka ɔrimɔni ɔrimɔni (estrogène) bɔ (a ka ca a la a bɛ di musow ma minnu bɛ kalolabɔ kɔfɛ). Misaliw: Anastrozole (Arimidex), Letrozole (Femara) .
LHRH Agonistew (Agonistes) ye Olu bɛ kɔnɔbara basigilenw bali ka ɔrimɔni bɔ waati dɔɔni. Misaliw: Goserelini (Zoladex), Leuprolide (Lupron) .
Furakɛcogo wɛrɛw minnu ɲɛsinnen don u ma Fura wɛrɛ minnu bɛ dɔ fara ɔrimɔni furakɛli ɲɛtaa kan. Misaliw: Palbosilib (Ibrance), Ribosiklib (Kisqali), Alpelisib (Piqray) .

HER2-Sin kansɛri min bɛ sɔrɔ

Sisan an ka kuma sugu wɛrɛ kan. Sinna kansɛri banakisɛ dɔw (kansɛri bɛɛ la 20% ɲɔgɔn) bɛ farikolojɔli dumuni kɛrɛnkɛrɛnnen dɔ dilan kojugu u ɲɛda la min bɛ wele ko HER2 (Human Epidermal growth factor Receptor 2) .

Aw ye miiri HER2 la i n’a fɔ antɛni fitinin min b’a fɔ kansɛribana ye ko a “ka bonya joona, ka tila joona.” Seli normal kɔnɔ, o antɛni damadɔw dɔrɔn de bɛ yen. Nka kansɛribanakisɛ min bɛ HER2 sɔrɔ, o antɛni caman bɛ o la. o de kama nin kansɛri suguya ninnu bɛ se ka juguya ka tɛmɛ .

Nka kibaru duman bɛ yan fana. Ni ɲɛtaa kɛra dɔnniya la, sisan " furakɛli laɲinitaw " bɛ yen minnu bɛ nin HER2 antɛniw yɛrɛ laɲini ani k'u tiɲɛ. Ikomi ninnu bɛ farikolokisɛw dɔrɔn de sɔrɔ ka bin u kan, HER2 caman bɛ minnu na, o la, tiɲɛni bɛ dɔgɔya farikolokisɛw la minnu ka ɲi.

Fura kunba min bɛ di o ma ani min bɛ se ka kɛ kosɛbɛ, o ye Trastuzumab (Herceptin) ye . O bɛ dɛmɛba lase kansɛri bali ka segin. Nka, farati fitini bɛ nɔ dɔw la dusukun walima fogonfogon la ni aw bɛ nin furakɛli in ta. Aw kana aw hakili ɲagami o la , aw ka dɔgɔtɔrɔ bɛna a lajɛ tuma bɛɛ.

Furakɛcogo wɛrɛw laɲinitaw minnu bɛ kɛ kansɛriw la minnu bɛ sɔrɔ HER2 fɛ
Pɛrituzumabi (Perjeta) . Ado-trastuzumab ɛmɛtansini (Kadcyla) .
Lapatinibi (Tykerb) . Nɛrɛtinibi (Nerlynx) .
Tukatinibi (Tukysa) . Enhertu (Fam-trastuzumab deruxtecan-nxki) ye fura ye.

"Triple-Negative" Sinbara kansɛri

Nin ye suguba sabanan ye. Sinna kansɛri 10%-20% ɲɔgɔn bɛ bin nin suguya in na. Yala i b'a dɔn mun na a bɛ wele ko "triple-negatif" walima "triple negative" wa?

Sabula o kansɛribanakisɛw la , .

1. Ɔsitosini tali (ETU) tɛ a la .

2. Porojɛsitɛri tali (PR) tɛ a la .

3. HER2 farikolojɔli dumuni caman tɛ yen .

Ikomi nin kansɛribana ninnu tɛ ni laɲiniba saba ye an ye minnu baro kɛ ka tɛmɛ, ɔrimɔni furakɛli walima HER2 laɲini furakɛli i n’a fɔ Ɛrsɛti, olu si tɛ baara kɛ u kan. O la sa, u furakɛli bɛ se ka gɛlɛya dɔɔni.

Nin kansɛri suguya in ka teli ka sɔrɔ BRCA1 fɛ.A bɛ tali kɛ fɛn dɔ jiginni na jɛnɛya dɔ la min bɛ wele ko . O la ni kansɛri saba bɛ aw la, aw ka dɔgɔtɔrɔ bɛ se ka a fɔ aw ye fana ko aw ka jamu sɛgɛsɛgɛli kɛ.

Nin suguya in bɛ furakɛ kosɛbɛ ni opereli ye, ni chimiothérapie ye ani ni fiɲɛ ye . Nka, furakɛli kura dɔw bɛ yen sisan minnu kɛrɛnkɛrɛnnen don nin suguya in na.

  • PARP balilanw : Fura minnu bɛ i n’a fɔ Olaparib (Lynparza) ani Talazoparib (Talzenna) olu bɛ kɛ mɔgɔw la minnu ka BRCA jamu caman bɛ ɲɔgɔn falen. Olu bɛ kansɛribanakisɛw ka se bali ka u yɛrɛ dilan.
  • Banakisɛfagalanw : Fura minnu bɛ i n’a fɔ Atezolizumab (Tecentriq) olu bɛ kansɛribanakisɛw kɛlɛ ni an yɛrɛ ka farikolo tangalanw ye.

Nin bɛɛ bɛ se ka kɛ i n’a fɔ a ka gɛlɛn dɔɔnin. O ye ko ye min tɛ kojugu ye. Min nafa ka bon, o ye k’aw hakili to a la ko kansɛri suguya o suguya mana kɛ aw la, furakɛli dɔw bɛ yen bi minnu bɛ bɛn a ma. Aw ka dɔgɔtɔrɔ ni dɔgɔtɔrɔso jɛkulu bɛna baara kɛ ni aw ye walasa ka furakɛlicogo ɲuman dilan aw ye.

Take-Home cikan

  • Sinna kansɛri tilalen don suguya 3 ye: Hormone Recepteur-Positif, HER2-Positif, ani Triple-Negatif .
  • Kansɛri suguya min bɛ aw la, o dɔnni nafa ka bon furakɛli bolodacogo la.
  • Kansɛri minnu bɛ sɔrɔ ɔrimɔni fɛ, olu bɛ jaabi ɲuman di ɔrimɔni furakɛli ma.
  • Hali ni kansɛri minnu bɛ sɔrɔ HER2 fɛ, olu bɛ bonya joona, furakɛli kuntaalajanw bɛ yen minnu bɛ se ka kɛ kosɛbɛ, minnu dabɔra u kama kɛrɛnkɛrɛnnenya la.
  • Hali ni kansɛri saba furakɛli ye gɛlɛya ye, u bɛ se ka kɛlɛ ni chimiothérapie ni furakɛli kura laɲinitaw ye.
  • Ni ɲininkali dɔw bɛ aw fɛ fɛn o fɛn kan aw ka furakɛli sɛbɛnw kɔnɔ, aw kana siran ka ɲininkali kɛ . Aw bɛ dɔgɔtɔrɔ ɲininka a ka ɲɛfɔli jɛlen di a ma. I kelen tɛ, wa mɔgɔ caman bɛ yen minnu bɛ se k’i dɛmɛ.

Sinna kansɛri, sinji kansɛri, kansɛri suguyaw, Hormone-Positive, HER2-Positive, Triple-Negative, kansɛri furakɛli, musow ka kɛnɛya
⚠️ Important: The medical articles and information on Nirogi Lanka are for general awareness only, and are by no means a substitute for professional medical advice, diagnosis, or treatment. For any medical problem you have, consult a qualified physician immediately.

💬 Comments (0)

Ko foyi ma bila fɔlɔ. Aw ka kuma fɔlen fara a kan yan a siɲɛ fɔlɔ la.

Aw ka kuma fɔlen fara a kan

Aw ye jatebɔ kɛ: 8 + 6 =
Sinna kansɛri suguya jɔnjɔnw ye jumɛnw ye? (Sin kansɛri suguyaw) An k’a faamuya cogo nɔgɔman na
Musow ka Kɛnɛya6 zuluye 2026

Sinna kansɛri suguya jɔnjɔnw ye jumɛnw ye? (Sin kansɛri suguyaw) An k’a faamuya cogo nɔgɔman na

Siran ni sɛgɛn min bɛ i la ni i y’a ye ko sinji kansɛri bɛ i la, a ka gɛlɛn ka o fɔ daɲɛw la. Ɲininkali caman bɛ i hakili la kosɛbɛ. A bɛ kɛ cogoya la ka ɲininkaliw kɛ i n'a fɔ "Mun na nin kɛra ne la?", "Ne bɛ mun kɛ sisan?", "Yala nin bɛ se ka furakɛ wa?". Nin taama in na, n b’a ɲini ka fɛnw ɲɛfɔ cogo nɔgɔman na ani kan na i bɛ se ka min faamuya. K’a dɔn tigitigi kansɛri suguya min bɛ i la, o bɛ i n’a fɔ ka jugu faamuya sani i ka kɛlɛ daminɛ. O de ye fɛɛrɛ fɔlɔ ye min nafa ka bon kosɛbɛ furakɛli sugandili la min bɛ bɛn aw ma.

Sinna kansɛri min bɛ sɔrɔ ɔrimɔni minɛbaga fɛ

Nin ye sinji kansɛri suguya ye min ka ca. Ni an y’a fɔ k’a jɛya, sinji kansɛri 100 o 100, 80 ɲɔgɔn bɛ don o kulu kɔnɔ.

O la, nin "hormone-dependent" in kɔrɔ ye mun ye?

Miiri o la dɔrɔn. An farikolo, kɛrɛnkɛrɛnnenya la musow farikolo, bɛ ni ɔrimɔni fila ye minnu bɛ sɔrɔ u yɛrɛ la, n’olu bɛ wele ko ɔrimɔni ni porojɛsitɛri . Olu nafa ka bon kosɛbɛ taabolo nɔgɔmanw na an farikolo la. Nka, kansɛribana dɔw bɛ "dɔlɔminna" kosɛbɛ o ɔrimɔni ninnu na. O kɔrɔ ye ko nin kansɛribana ninnu sanfɛ, "recepteurs" walima da dɔw bɛ yen, o ɔrimɔni ninnu bɛ se ka na minnu na ka nɔrɔ u la. Ni ɔrimɔni ɔrimɔni nana o da gosi, kansɛribanakisɛ bɛ balo sɔrɔ a la, wa a bɛ daminɛ ka bonya ka tila. I n’a fɔ n’i ye jiri dɔ jigin cogo min na, a bɛ bonya ka taa a fɛ cogo min na.

Ni aw ka furakɛli sɛbɛn ko `ER-positive` (Estrogen Receptor-Positive), o kɔrɔ ye ko aw ka kansɛribanakisɛw bɛ u yɛrɛ minɛ ɔrimɔni ɔrimɔni na. Ni a ko `PR-positif` (Progesterone Receptor-Positive), o kɔrɔ ye ko a bɛ porojɛsitɛri ɔrimɔni sɛgɛsɛgɛ. Ni a bɛ se ka ninnu dɔ la kelen sɔrɔ, kansɛri bɛ wele ko kansɛri min bɛ sɔrɔ ɔrimɔni minɛbaga fɛ .

Tiɲɛ na, nin ye kibaru duman ye cogo dɔ la. Sabula n’an y’a dɔn kansɛri bɛ baara kɛ ni min ye ka bonya, an bɛ se k’o sira bali ka kansɛri kunbɛn. O de ye "hormone therapy" ye.

A ka ca a la, ɔrimɔni furakɛli bɛ kɛ opereli, chimiothérapie walima radiyodisiyɔn kɔfɛ walasa kansɛri kana segin ka na. O fura ninnu bɛ baara kɛ ni kansɛribanakisɛw ka "da" datuguli ye, walima ka farikolo bali ka ɔrimɔni dilan.

Furakɛli suguyaƝɛfɔli nɔgɔmanw ni misaliw
SERMw (ER Modulateurs sélectifs) . Olu bɛ ɔrimɔni minɛbaga bali kansɛribanakisɛ la, o bɛ ɔrimɔni bali ka don. Misaliw: Tamokisifɛni, Toremifeni .
SERDw (Estrogène récepteur degradeurs sélectifs) . Olu tɛ a minɛbaga bali dɔrɔn, nka u b’a tiɲɛ fana. Misaliw: Fulvestrant (Faslodex), Elacestrant (Orserdu) .
Aromatase (Aromatase) balilanw Olu bɛ farikolo bali ka ɔrimɔni ɔrimɔni (estrogène) bɔ (a ka ca a la a bɛ di musow ma minnu bɛ kalolabɔ kɔfɛ). Misaliw: Anastrozole (Arimidex), Letrozole (Femara) .
LHRH Agonistew (Agonistes) ye Olu bɛ kɔnɔbara basigilenw bali ka ɔrimɔni bɔ waati dɔɔni. Misaliw: Goserelini (Zoladex), Leuprolide (Lupron) .
Furakɛcogo wɛrɛw minnu ɲɛsinnen don u ma Fura wɛrɛ minnu bɛ dɔ fara ɔrimɔni furakɛli ɲɛtaa kan. Misaliw: Palbosilib (Ibrance), Ribosiklib (Kisqali), Alpelisib (Piqray) .

HER2-Sin kansɛri min bɛ sɔrɔ

Sisan an ka kuma sugu wɛrɛ kan. Sinna kansɛri banakisɛ dɔw (kansɛri bɛɛ la 20% ɲɔgɔn) bɛ farikolojɔli dumuni kɛrɛnkɛrɛnnen dɔ dilan kojugu u ɲɛda la min bɛ wele ko HER2 (Human Epidermal growth factor Receptor 2) .

Aw ye miiri HER2 la i n’a fɔ antɛni fitinin min b’a fɔ kansɛribana ye ko a “ka bonya joona, ka tila joona.” Seli normal kɔnɔ, o antɛni damadɔw dɔrɔn de bɛ yen. Nka kansɛribanakisɛ min bɛ HER2 sɔrɔ, o antɛni caman bɛ o la. o de kama nin kansɛri suguya ninnu bɛ se ka juguya ka tɛmɛ .

Nka kibaru duman bɛ yan fana. Ni ɲɛtaa kɛra dɔnniya la, sisan " furakɛli laɲinitaw " bɛ yen minnu bɛ nin HER2 antɛniw yɛrɛ laɲini ani k'u tiɲɛ. Ikomi ninnu bɛ farikolokisɛw dɔrɔn de sɔrɔ ka bin u kan, HER2 caman bɛ minnu na, o la, tiɲɛni bɛ dɔgɔya farikolokisɛw la minnu ka ɲi.

Fura kunba min bɛ di o ma ani min bɛ se ka kɛ kosɛbɛ, o ye Trastuzumab (Herceptin) ye . O bɛ dɛmɛba lase kansɛri bali ka segin. Nka, farati fitini bɛ nɔ dɔw la dusukun walima fogonfogon la ni aw bɛ nin furakɛli in ta. Aw kana aw hakili ɲagami o la , aw ka dɔgɔtɔrɔ bɛna a lajɛ tuma bɛɛ.

Furakɛcogo wɛrɛw laɲinitaw minnu bɛ kɛ kansɛriw la minnu bɛ sɔrɔ HER2 fɛ
Pɛrituzumabi (Perjeta) . Ado-trastuzumab ɛmɛtansini (Kadcyla) .
Lapatinibi (Tykerb) . Nɛrɛtinibi (Nerlynx) .
Tukatinibi (Tukysa) . Enhertu (Fam-trastuzumab deruxtecan-nxki) ye fura ye.

"Triple-Negative" Sinbara kansɛri

Nin ye suguba sabanan ye. Sinna kansɛri 10%-20% ɲɔgɔn bɛ bin nin suguya in na. Yala i b'a dɔn mun na a bɛ wele ko "triple-negatif" walima "triple negative" wa?

Sabula o kansɛribanakisɛw la , .

1. Ɔsitosini tali (ETU) tɛ a la .

2. Porojɛsitɛri tali (PR) tɛ a la .

3. HER2 farikolojɔli dumuni caman tɛ yen .

Ikomi nin kansɛribana ninnu tɛ ni laɲiniba saba ye an ye minnu baro kɛ ka tɛmɛ, ɔrimɔni furakɛli walima HER2 laɲini furakɛli i n’a fɔ Ɛrsɛti, olu si tɛ baara kɛ u kan. O la sa, u furakɛli bɛ se ka gɛlɛya dɔɔni.

Nin kansɛri suguya in ka teli ka sɔrɔ BRCA1 fɛ.A bɛ tali kɛ fɛn dɔ jiginni na jɛnɛya dɔ la min bɛ wele ko . O la ni kansɛri saba bɛ aw la, aw ka dɔgɔtɔrɔ bɛ se ka a fɔ aw ye fana ko aw ka jamu sɛgɛsɛgɛli kɛ.

Nin suguya in bɛ furakɛ kosɛbɛ ni opereli ye, ni chimiothérapie ye ani ni fiɲɛ ye . Nka, furakɛli kura dɔw bɛ yen sisan minnu kɛrɛnkɛrɛnnen don nin suguya in na.

  • PARP balilanw : Fura minnu bɛ i n’a fɔ Olaparib (Lynparza) ani Talazoparib (Talzenna) olu bɛ kɛ mɔgɔw la minnu ka BRCA jamu caman bɛ ɲɔgɔn falen. Olu bɛ kansɛribanakisɛw ka se bali ka u yɛrɛ dilan.
  • Banakisɛfagalanw : Fura minnu bɛ i n’a fɔ Atezolizumab (Tecentriq) olu bɛ kansɛribanakisɛw kɛlɛ ni an yɛrɛ ka farikolo tangalanw ye.

Nin bɛɛ bɛ se ka kɛ i n’a fɔ a ka gɛlɛn dɔɔnin. O ye ko ye min tɛ kojugu ye. Min nafa ka bon, o ye k’aw hakili to a la ko kansɛri suguya o suguya mana kɛ aw la, furakɛli dɔw bɛ yen bi minnu bɛ bɛn a ma. Aw ka dɔgɔtɔrɔ ni dɔgɔtɔrɔso jɛkulu bɛna baara kɛ ni aw ye walasa ka furakɛlicogo ɲuman dilan aw ye.

Take-Home cikan

  • Sinna kansɛri tilalen don suguya 3 ye: Hormone Recepteur-Positif, HER2-Positif, ani Triple-Negatif .
  • Kansɛri suguya min bɛ aw la, o dɔnni nafa ka bon furakɛli bolodacogo la.
  • Kansɛri minnu bɛ sɔrɔ ɔrimɔni fɛ, olu bɛ jaabi ɲuman di ɔrimɔni furakɛli ma.
  • Hali ni kansɛri minnu bɛ sɔrɔ HER2 fɛ, olu bɛ bonya joona, furakɛli kuntaalajanw bɛ yen minnu bɛ se ka kɛ kosɛbɛ, minnu dabɔra u kama kɛrɛnkɛrɛnnenya la.
  • Hali ni kansɛri saba furakɛli ye gɛlɛya ye, u bɛ se ka kɛlɛ ni chimiothérapie ni furakɛli kura laɲinitaw ye.
  • Ni ɲininkali dɔw bɛ aw fɛ fɛn o fɛn kan aw ka furakɛli sɛbɛnw kɔnɔ, aw kana siran ka ɲininkali kɛ . Aw bɛ dɔgɔtɔrɔ ɲininka a ka ɲɛfɔli jɛlen di a ma. I kelen tɛ, wa mɔgɔ caman bɛ yen minnu bɛ se k’i dɛmɛ.

Sinna kansɛri, sinji kansɛri, kansɛri suguyaw, Hormone-Positive, HER2-Positive, Triple-Negative, kansɛri furakɛli, musow ka kɛnɛya
⚠️ Important: The medical articles and information on Nirogi Lanka are for general awareness only, and are by no means a substitute for professional medical advice, diagnosis, or treatment. For any medical problem you have, consult a qualified physician immediately.

💬 Comments (0)

Ko foyi ma bila fɔlɔ. Aw ka kuma fɔlen fara a kan yan a siɲɛ fɔlɔ la.

Aw ka kuma fɔlen fara a kan

Aw ye jatebɔ kɛ: 8 + 6 =